Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Alzheimer Disease: HELP
Richard C. Mohs
Based on 16 articles published since 2010
(Why 16 articles?)
||||
Expertise Level
The expertise of Richard C. Mohs ranks in the
  • Top 2.1%
  • ... of 135,371 published authors worldwide on Alzheimer Disease
  • ... from 2010 through 2020
  • ... based on contributions to 16 articles on the topic.
Graphical view (beta)
Aliases Mohs, R   ·   Mohs, Richard   ·   Mohs, Richard C
Work Locations
Details
Most likely:    Alzheimer's Association      
2018
  • Executive Editor, Alzheimer's & Dementia: The Journal of the Alzheimer's Association, Rockville, MD, USA. Electronic address: · Associate Professor, Wake Forest School of Medicine, Department of Social Sciences and Health Policy, Division of Public Health Sciences, Sticht Center for Healthy Aging and Alzheimer's Prevention, Winston-Salem, NC, USA. · Professor of Epidemiology, Department of Health Sciences Research, Professor of Neurology, Mayo Clinic College of Medicine, Rochester, MN, USA. · Associate Professor, Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, China. · Assistant Professor of Neurology, Department of Neurology, Duke University School of Medicine, Durham, NC, USA. · Vice-President, Development Neurosciences, AbbVie, Inc., North Chicago, IL, USA. · Professor, Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA. · Senior Associate Editor, Alzheimer's & Dementia: The Journal of the Alzheimer's Association, Chicago, IL, USA. · Director, McGill Centre for Studies in Aging, Montreal, QC, USA. · Scientific Director, Alzheimer Prevention Program, BarcelonaBeta Brain Research Center, Fundació Pasqual Maragall, Barcelona, Spain. · Professor of Neurochemistry, University of Gothenburg, Gothenburg, Sweden; University College London, London, United Kingdom. · Editor-in-Chief, Alzheimer's & Dementia: The Journal of the Alzheimer's Association, Rockville, MD, USA. · Pubmed 29842864
  • Alzheimer's & Dementia: The Journal of the Alzheimer's Association, Rockville, MD, USA. Electronic address: · Associate Professor, Division of Public Health Sciences, Department of Social Sciences and Health Policy, Sticht Center for Healthy Aging and Alzheimer's Prevention, Wake Forest School of Medicine, Winston-Salem, NC, USA. · Professor of Epidemiology, Department of Health Sciences Research, Professor of Neurology, Mayo Clinic College of Medicine, Rochester, MN, USA. · Associate Professor, Department of Neurology, Xuan Wu Hospital, Beijing, China. · Assistant Professor of Neurology, Department of Neurology, Duke University School of Medicine, Durham, NC, USA. · Professor, Section for NeuroEpidemiology, Department of Neurology, State University of New York-Downstate Medical Center, Brooklyn, NY, USA. · Professor, Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA. · Senior Associate Editor, Alzheimer's & Dementia: The Journal of the Alzheimer's Association, Chicago, IL, USA. · Alzheimer's & Dementia: The Journal of the Alzheimer's Association, Rockville, MD, USA. · Pubmed 29653605
Probable:    Eli Lilly Corporation      
2017
  • From the Department of Neurology (R.C.P.), Mayo Clinic College of Medicine, Rochester, MN · Department of Neurosciences (R.G.T.), University of California, San Diego, La Jolla · University of Southern California (P.S.A.), Los Angeles · Eli Lilly and Company (R.C.M.), Indianapolis, IN · Division of Medical & Scientific Relations (M.C.C.), Alzheimer's Association, Chicago, IL · and Johns Hopkins School of Medicine (M.S.A.), Baltimore, MD. R.C.M. is currently with Global Alzheimer's Platform Foundation, Washington, DC. · Pubmed 28381516
2015
  • Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA. · Indiana University School of Medicine, Indianapolis, IN, USA. · Department of Neurosciences, University of California San Diego, San Diego, CA, USA. · Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA. · Eli Lilly Canada, Toronto, Canada. · Pubmed 26402769
  • Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA. · Department of Neurosciences, University of California San Diego, San Diego, CA, USA. · Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA. · Eli Lilly Canada, Toronto, Canada. · Pubmed 25125457
2014
  • From the Alzheimer's Disease and Memory Disorders Center, Department of Neurology, Baylor College of Medicine, Houston (R.S.D.) · Alzheimer's Disease Cooperative Study, Department of Family and Preventive Medicine (R.G.T., R.R., X.S.), and the Department of Neurosciences (R.G.T., R.R., P.S.A., R.M.), University of California at San Diego, San Diego · Indiana Alzheimer Disease Center, Indiana University (M.F.), and Eli Lilly (E.S., H.L.-S., R.M.) - both in Indianapolis · the Department of Neuropathology, School of Medicine, and the Department of Neuropathology and Neuroscience, School of Pharmacological Science, University of Tokyo, Tokyo (T.I.) · Gerontopole, Unité Mixte de Recherche 1027, Centre Hospitalier Universitaire Toulouse, Toulouse, France (B.V.) · the Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia (S.J.) · and the Center for Human Experimental Therapeutics, University of Rochester Medical Center, Rochester, NY (K.K.). · Pubmed 24450890
  • Division of Medical and Scientific Relations, Alzheimer's Association, Chicago, IL. · Department of Neurosciences, University of California San Diego School of Medicine, San Diego, CA. · Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD. · Department of Neurology and Framingham Heart Study, Boston University School of Medicine, Boston, MD. · Department of Neurology and Department of Epidemiology, University of California, Irvine, CA. · Department of Neurology, University of Virginia, Charlottesville, VA; Department of Radiology and Department of Neurology, University of Pittsburgh, PA. · Department of Neurology, University of Massachusetts Medical School, Worcester, MA. · Alzheimer's Drug Discovery Foundation; Department of Geriatrics and Palliative Medicine and Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY. · Department of Community-Public Health and Department of Psychiatry, Johns Hopkins University, Baltimore, MD. · Orion Bionetworks, Cambridge, MA. · Division of Life Science and the State Key Laboratory of Molecular Neuroscience, Hong Kong University of Science and Technology, Kowloon, Hong Kong. · Department of Neurology, Department of Neurobiology & Behavior, and Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, CA. · National Biomedical Research Ethics Council, Rockville, MD. · PAD2020, Rockville, MD. · Department of Psychiatry, University of Pittsburgh, PA. · Department of Neurology, Mayo Clinic Alzheimer's Disease Research Center, Mayo Clinic College of Medicine, Rochester, MN. · National Alzheimer's Coordinating Center (NACC); and Department of Epidemiology, University of Washington, Seattle, WA. · Department of Neurosciences, Lerner Research Institute, The Cleveland Clinic, Cleveland, OH. · Department of Psychosocial and Community Health, University of Washington, Seattle, WA. · Florey Institute for Neuroscience and Mental Health, University of Melbourne; and CogState Ltd., Melbourne VIC, Australia. · Department of Neurology and Alzheimer's Disease Center, Feinberg School of Medicine, Northwestern University, Chicago, IL. · Neuroscience Early Clinical Development, Eli Lilly and Company, Indianapolis, IN. · Byrd Alzheimer's Institute, University of South Florida, Tampa, FL. · Department of Psychiatry and Department of Cell Biology, New York University Langone Medical Center, New York, NY; and The Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY. · Appel Alzheimer's Disease Research Institute, Weill Cornell Medical College, New York, NY; Foundation for the National Institutes of Health, Bethesda, MD. · Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC. · Neuroscience Steering Committee of the Biomarkers Consortium, Foundation of the National Institutes of Health (emeritus). · Banner Alzheimer's Institute; and Department of Psychiatry, University of Arizona College of Medicine, Phoenix, AZ. · Department of Psychiatry, New York University School of Medicine, New York, NY. · Department of Psychiatry; and Alzheimer's Disease Research Center, Mount Sinai School of Medicine, New York, NY. · Pfizer, Inc., New York, NY. · Department of Psychiatry and the Behavioral Sciences and Department of Neurology, Keck School of Medicine; and Leonard Davis School of Gerontology; University of Southern California, Los Angeles, CA. · Department of Neurology, Alpert Medical School of Brown University; and Department of Neurology, Rhode Island Hospital; Providence, RI. · Departments of Neurology, Brigham and Women's Hospital and Massachusetts General Hospital, Harvard Medical School, Boston, MA. · Department of Psychiatry and Department of Neurology, University of California, San Francisco; and San Francisco VA Medical Center, CA. · Independent Science Writer, Elverson, PA. · Division of Medical and Scientific Relations, Alzheimer's Association, Chicago, IL. Electronic address: · Pubmed 25341459
2018
  • Hong Liu-Seifert, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, Email: , Phone: +1 317-433-0662. · Pubmed 29972211
Probable:    Indiana University Indianapolis   Contact    
2014
  • From the Alzheimer's Disease and Memory Disorders Center, Department of Neurology, Baylor College of Medicine, Houston (R.S.D.) · Alzheimer's Disease Cooperative Study, Department of Family and Preventive Medicine (R.G.T., R.R., X.S.), and the Department of Neurosciences (R.G.T., R.R., P.S.A., R.M.), University of California at San Diego, San Diego · Indiana Alzheimer Disease Center, Indiana University (M.F.), and Eli Lilly (E.S., H.L.-S., R.M.) - both in Indianapolis · the Department of Neuropathology, School of Medicine, and the Department of Neuropathology and Neuroscience, School of Pharmacological Science, University of Tokyo, Tokyo (T.I.) · Gerontopole, Unité Mixte de Recherche 1027, Centre Hospitalier Universitaire Toulouse, Toulouse, France (B.V.) · the Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia (S.J.) · and the Center for Human Experimental Therapeutics, University of Rochester Medical Center, Rochester, NY (K.K.). · Pubmed 24450890
2012
  • Department of Neurology, Indiana University School of Medicine, Indianapolis, USA. · Pubmed 22672770
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 16 total) written by Richard C. Mohs about Alzheimer Disease:

  • New thinking about thinking, part two. Theoretical articles for Alzheimer's & Dementia. 2018
  • Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework. 2018
  • Analysis of the Relationship of Cognitive Impairment and Functional Impairment in Mild Alzheimer's Disease in EXPEDITION 3. 2018
  • Randomized controlled trials in mild cognitive impairment: Sources of variability. 2017
  • Toward a consensus recommendation for defining the asymptomatic-preclinical phases of putative Alzheimer's disease? 2016
  • The Special Topics Section of Alzheimer's & Dementia. 2015
  • Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease. 2015
  • Cognitive and functional decline and their relationship in patients with mild Alzheimer's dementia. 2015
  • The future is now: model-based clinical trial design for Alzheimer's disease. 2015
  • Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. 2014
Show List of Full Article Records
Google Searches

Learn more about Richard C. Mohs using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Alzheimer's Association
Eli Lilly Corporation
Indiana University Indianapolis
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Alzheimer's Association
2018
  • Executive Editor, Alzheimer's & Dementia: The Journal of the Alzheimer's Association, Rockville, MD, USA. Electronic address: · Associate Professor, Wake Forest School of Medicine, Department of Social Sciences and Health Policy, Division of Public Health Sciences, Sticht Center for Healthy Aging and Alzheimer's Prevention, Winston-Salem, NC, USA. · Professor of Epidemiology, Department of Health Sciences Research, Professor of Neurology, Mayo Clinic College of Medicine, Rochester, MN, USA. · Associate Professor, Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, China. · Assistant Professor of Neurology, Department of Neurology, Duke University School of Medicine, Durham, NC, USA. · Vice-President, Development Neurosciences, AbbVie, Inc., North Chicago, IL, USA. · Professor, Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA. · Senior Associate Editor, Alzheimer's & Dementia: The Journal of the Alzheimer's Association, Chicago, IL, USA. · Director, McGill Centre for Studies in Aging, Montreal, QC, USA. · Scientific Director, Alzheimer Prevention Program, BarcelonaBeta Brain Research Center, Fundació Pasqual Maragall, Barcelona, Spain. · Professor of Neurochemistry, University of Gothenburg, Gothenburg, Sweden; University College London, London, United Kingdom. · Editor-in-Chief, Alzheimer's & Dementia: The Journal of the Alzheimer's Association, Rockville, MD, USA. · Pubmed 29842864
  • Alzheimer's & Dementia: The Journal of the Alzheimer's Association, Rockville, MD, USA. Electronic address: · Associate Professor, Division of Public Health Sciences, Department of Social Sciences and Health Policy, Sticht Center for Healthy Aging and Alzheimer's Prevention, Wake Forest School of Medicine, Winston-Salem, NC, USA. · Professor of Epidemiology, Department of Health Sciences Research, Professor of Neurology, Mayo Clinic College of Medicine, Rochester, MN, USA. · Associate Professor, Department of Neurology, Xuan Wu Hospital, Beijing, China. · Assistant Professor of Neurology, Department of Neurology, Duke University School of Medicine, Durham, NC, USA. · Professor, Section for NeuroEpidemiology, Department of Neurology, State University of New York-Downstate Medical Center, Brooklyn, NY, USA. · Professor, Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA. · Senior Associate Editor, Alzheimer's & Dementia: The Journal of the Alzheimer's Association, Chicago, IL, USA. · Alzheimer's & Dementia: The Journal of the Alzheimer's Association, Rockville, MD, USA. · Pubmed 29653605
Eli Lilly Corporation
2017
  • From the Department of Neurology (R.C.P.), Mayo Clinic College of Medicine, Rochester, MN · Department of Neurosciences (R.G.T.), University of California, San Diego, La Jolla · University of Southern California (P.S.A.), Los Angeles · Eli Lilly and Company (R.C.M.), Indianapolis, IN · Division of Medical & Scientific Relations (M.C.C.), Alzheimer's Association, Chicago, IL · and Johns Hopkins School of Medicine (M.S.A.), Baltimore, MD. R.C.M. is currently with Global Alzheimer's Platform Foundation, Washington, DC. · Pubmed 28381516
2015
  • Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA. · Indiana University School of Medicine, Indianapolis, IN, USA. · Department of Neurosciences, University of California San Diego, San Diego, CA, USA. · Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA. · Eli Lilly Canada, Toronto, Canada. · Pubmed 26402769
  • Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN, USA. · Department of Neurosciences, University of California San Diego, San Diego, CA, USA. · Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA. · Eli Lilly Canada, Toronto, Canada. · Pubmed 25125457
2014
  • From the Alzheimer's Disease and Memory Disorders Center, Department of Neurology, Baylor College of Medicine, Houston (R.S.D.) · Alzheimer's Disease Cooperative Study, Department of Family and Preventive Medicine (R.G.T., R.R., X.S.), and the Department of Neurosciences (R.G.T., R.R., P.S.A., R.M.), University of California at San Diego, San Diego · Indiana Alzheimer Disease Center, Indiana University (M.F.), and Eli Lilly (E.S., H.L.-S., R.M.) - both in Indianapolis · the Department of Neuropathology, School of Medicine, and the Department of Neuropathology and Neuroscience, School of Pharmacological Science, University of Tokyo, Tokyo (T.I.) · Gerontopole, Unité Mixte de Recherche 1027, Centre Hospitalier Universitaire Toulouse, Toulouse, France (B.V.) · the Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia (S.J.) · and the Center for Human Experimental Therapeutics, University of Rochester Medical Center, Rochester, NY (K.K.). · Pubmed 24450890
  • Division of Medical and Scientific Relations, Alzheimer's Association, Chicago, IL. · Department of Neurosciences, University of California San Diego School of Medicine, San Diego, CA. · Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD. · Department of Neurology and Framingham Heart Study, Boston University School of Medicine, Boston, MD. · Department of Neurology and Department of Epidemiology, University of California, Irvine, CA. · Department of Neurology, University of Virginia, Charlottesville, VA; Department of Radiology and Department of Neurology, University of Pittsburgh, PA. · Department of Neurology, University of Massachusetts Medical School, Worcester, MA. · Alzheimer's Drug Discovery Foundation; Department of Geriatrics and Palliative Medicine and Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY. · Department of Community-Public Health and Department of Psychiatry, Johns Hopkins University, Baltimore, MD. · Orion Bionetworks, Cambridge, MA. · Division of Life Science and the State Key Laboratory of Molecular Neuroscience, Hong Kong University of Science and Technology, Kowloon, Hong Kong. · Department of Neurology, Department of Neurobiology & Behavior, and Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, CA. · National Biomedical Research Ethics Council, Rockville, MD. · PAD2020, Rockville, MD. · Department of Psychiatry, University of Pittsburgh, PA. · Department of Neurology, Mayo Clinic Alzheimer's Disease Research Center, Mayo Clinic College of Medicine, Rochester, MN. · National Alzheimer's Coordinating Center (NACC); and Department of Epidemiology, University of Washington, Seattle, WA. · Department of Neurosciences, Lerner Research Institute, The Cleveland Clinic, Cleveland, OH. · Department of Psychosocial and Community Health, University of Washington, Seattle, WA. · Florey Institute for Neuroscience and Mental Health, University of Melbourne; and CogState Ltd., Melbourne VIC, Australia. · Department of Neurology and Alzheimer's Disease Center, Feinberg School of Medicine, Northwestern University, Chicago, IL. · Neuroscience Early Clinical Development, Eli Lilly and Company, Indianapolis, IN. · Byrd Alzheimer's Institute, University of South Florida, Tampa, FL. · Department of Psychiatry and Department of Cell Biology, New York University Langone Medical Center, New York, NY; and The Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY. · Appel Alzheimer's Disease Research Institute, Weill Cornell Medical College, New York, NY; Foundation for the National Institutes of Health, Bethesda, MD. · Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC. · Neuroscience Steering Committee of the Biomarkers Consortium, Foundation of the National Institutes of Health (emeritus). · Banner Alzheimer's Institute; and Department of Psychiatry, University of Arizona College of Medicine, Phoenix, AZ. · Department of Psychiatry, New York University School of Medicine, New York, NY. · Department of Psychiatry; and Alzheimer's Disease Research Center, Mount Sinai School of Medicine, New York, NY. · Pfizer, Inc., New York, NY. · Department of Psychiatry and the Behavioral Sciences and Department of Neurology, Keck School of Medicine; and Leonard Davis School of Gerontology; University of Southern California, Los Angeles, CA. · Department of Neurology, Alpert Medical School of Brown University; and Department of Neurology, Rhode Island Hospital; Providence, RI. · Departments of Neurology, Brigham and Women's Hospital and Massachusetts General Hospital, Harvard Medical School, Boston, MA. · Department of Psychiatry and Department of Neurology, University of California, San Francisco; and San Francisco VA Medical Center, CA. · Independent Science Writer, Elverson, PA. · Division of Medical and Scientific Relations, Alzheimer's Association, Chicago, IL. Electronic address: · Pubmed 25341459
2018
  • Hong Liu-Seifert, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, Email: , Phone: +1 317-433-0662. · Pubmed 29972211
Unspecified
2016
  • Editors, Special Topics Section of Alzheimer's & Dementia. · Editors, Special Topics Section of Alzheimer's & Dementia. Electronic address: · Pubmed 27012483
2015
  • Editors, Special Topics Section of Alzheimer's & Dementia. · Editors, Special Topics Section of Alzheimer's & Dementia. Electronic address: · Pubmed 26589667
2010
Indiana University Indianapolis
2014
  • From the Alzheimer's Disease and Memory Disorders Center, Department of Neurology, Baylor College of Medicine, Houston (R.S.D.) · Alzheimer's Disease Cooperative Study, Department of Family and Preventive Medicine (R.G.T., R.R., X.S.), and the Department of Neurosciences (R.G.T., R.R., P.S.A., R.M.), University of California at San Diego, San Diego · Indiana Alzheimer Disease Center, Indiana University (M.F.), and Eli Lilly (E.S., H.L.-S., R.M.) - both in Indianapolis · the Department of Neuropathology, School of Medicine, and the Department of Neuropathology and Neuroscience, School of Pharmacological Science, University of Tokyo, Tokyo (T.I.) · Gerontopole, Unité Mixte de Recherche 1027, Centre Hospitalier Universitaire Toulouse, Toulouse, France (B.V.) · the Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia (S.J.) · and the Center for Human Experimental Therapeutics, University of Rochester Medical Center, Rochester, NY (K.K.). · Pubmed 24450890
2012
  • Department of Neurology, Indiana University School of Medicine, Indianapolis, USA. · Pubmed 22672770
University of California San Diego
2014
  • From the Alzheimer's Disease and Memory Disorders Center, Department of Neurology, Baylor College of Medicine, Houston (R.S.D.) · Alzheimer's Disease Cooperative Study, Department of Family and Preventive Medicine (R.G.T., R.R., X.S.), and the Department of Neurosciences (R.G.T., R.R., P.S.A., R.M.), University of California at San Diego, San Diego · Indiana Alzheimer Disease Center, Indiana University (M.F.), and Eli Lilly (E.S., H.L.-S., R.M.) - both in Indianapolis · the Department of Neuropathology, School of Medicine, and the Department of Neuropathology and Neuroscience, School of Pharmacological Science, University of Tokyo, Tokyo (T.I.) · Gerontopole, Unité Mixte de Recherche 1027, Centre Hospitalier Universitaire Toulouse, Toulouse, France (B.V.) · the Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia (S.J.) · and the Center for Human Experimental Therapeutics, University of Rochester Medical Center, Rochester, NY (K.K.). · Pubmed 24450890
4 Other Locations Show
Yearly article counts 00311421121
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.